- Home
- PBH vs VCYT Comparison
PBH vs VCYT Comparison
Compare PBH & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PBH | VCYT |
|---|---|---|
| Founded | 1996 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 3.1B |
| IPO Year | 2004 | 2013 |
Fundamental Metrics
Financial Performance| Metric | PBH | VCYT |
|---|---|---|
| Price | $47.67 | $47.12 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $75.33 | $44.00 |
| AVG Volume (30 Days) | 774.2K | ★ 1.1M |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 164.52 |
| EPS | ★ 3.91 | 0.35 |
| Revenue | ★ $975,777,000.00 | N/A |
| Revenue This Year | N/A | $13.76 |
| Revenue Next Year | $4.31 | $12.35 |
| P/E Ratio | ★ $12.17 | $137.30 |
| Revenue Growth | ★ 36.77 | N/A |
| 52 Week Low | $42.62 | $22.61 |
| 52 Week High | $85.29 | $50.71 |
Technical Indicators
Market Signals| Indicator | PBH | VCYT |
|---|---|---|
| Relative Strength Index (RSI) | 41.64 | 59.10 |
| Support Level | $44.51 | $40.27 |
| Resistance Level | $49.21 | $50.63 |
| Average True Range (ATR) | 1.55 | 2.33 |
| MACD | 0.49 | -0.34 |
| Stochastic Oscillator | 53.35 | 54.47 |
Price Performance
Historical ComparisonAbout PBH Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).